EUS Prior to ERCP in the Positive Setting of Positive Intraoperative Cholangiogram (IOC) During Cholecystectomy
A Prospective Study Evaluation the Role of EUS Prior to ERCP in the "Positive" Setting of Positive Intraoperative Cholangiogram (IOC) During Cholecystectomy
1 other identifier
observational
34
1 country
1
Brief Summary
Performing an EUS prior to ERCP in the setting of a positive intraoperative cholangiogram will identify and risk stratify patients for the presence of CBD stones and strictures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2010
CompletedFirst Submitted
Initial submission to the registry
January 30, 2012
CompletedFirst Posted
Study publicly available on registry
February 2, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 7, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 7, 2016
CompletedNovember 7, 2017
April 1, 2017
5.7 years
January 30, 2012
November 3, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bile Duct
Stone seen by EUS confirmed by ERCP
2 years
Secondary Outcomes (5)
Lesions
2 Years
Bile duct
2 years
Diverticulum
2 years
ERCP
2 years
ERCP
2 years
Study Arms (1)
EUS prior to ERCP
Eligibility Criteria
Patients who have gone an uncomplicated cholesytectomy and determined to have a "positive intraoperative cholangiogram" within one month of presentation to Wake Forest Baptist Health.
You may qualify if:
- Subjects must be able to review and sign informed consent
- Cholecystectomy must have been performed within one month of enrollment
- Positive intraoperative cholangiogram
- Stone
- Multiple Stones
- Stenosis
- "non filling" of duodenum
- Dilated bile duct
You may not qualify if:
- Cannot give and sign informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wake Forest Baptist Health
Winston-Salem, North Carolina, 27157, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John A Evans, MD
Wake Forest University Baptist Health
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 30, 2012
First Posted
February 2, 2012
Study Start
October 1, 2010
Primary Completion
June 7, 2016
Study Completion
June 7, 2016
Last Updated
November 7, 2017
Record last verified: 2017-04